Korean J Hepatol.
2008 Sep;14(3):305-308. 10.3350/kjhep.2008.14.3.305.
Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor
- Affiliations
-
- 1Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea. garden@catholic.ac.kr
- KMID: 1381460
- DOI: http://doi.org/10.3350/kjhep.2008.14.3.305
Abstract
- No abstract available.
MeSH Terms
-
Carcinoma, Hepatocellular/enzymology/*metabolism/pathology
Cell Proliferation/drug effects
Cyclooxygenase 2 Inhibitors/*pharmacology
Cyclooxygenase Inhibitors/pharmacology
Humans
Liver Neoplasms/enzymology/*metabolism/pathology
Microtubule-Associated Proteins/*antagonists & inhibitors/metabolism
Neoplasm Proteins/*antagonists & inhibitors/metabolism
Nitrobenzenes/pharmacology
Sulfonamides/pharmacology
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor
- The Expression of Cyclooxygenase-2 and Survivin in Urinary Bladder Transitional Cell Carcinoma
- Survivin Expression in Brain Tumors: Relevance of Apoptosis and Histological Malignancy
- Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
- The Immunohistochemical analysis for the expression of survivin, an inhibitor of apoptosis protein, in non-small cell lung cancer
